
Medpace Holdings Inc
NASDAQ:MEDP

Intrinsic Value
The intrinsic value of one
MEDP
stock under the Base Case scenario is
286.85
USD.
Compared to the current market price of 298.25 USD,
Medpace Holdings Inc
is
Overvalued by 4%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Medpace Holdings Inc
Fundamental Analysis

Medpace’s heavy reliance on smaller biotech and emerging pharma clients could backfire if funding conditions tighten, as these customers often struggle to secure sustained capital for drug development, directly impacting Medpace’s project pipeline and revenue growth.
Medpace’s niche expertise in full-service clinical trial management for small to mid-sized biotech firms positions it to capture growing demand for specialized drug development support, particularly in oncology and rare diseases where innovation is robust.

Revenue & Expenses Breakdown
Medpace Holdings Inc
Balance Sheet Decomposition
Medpace Holdings Inc
Current Assets | 821.4m |
Cash & Short-Term Investments | 441.4m |
Receivables | 298.2m |
Other Current Assets | 81.8m |
Non-Current Assets | 1.1B |
PP&E | 258.2m |
Intangibles | 696.5m |
Other Non-Current Assets | 121.2m |
Free Cash Flow Analysis
Medpace Holdings Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Medpace Holdings Inc
Revenue
|
2.2B
USD
|
Cost of Revenue
|
-1.5B
USD
|
Gross Profit
|
679.5m
USD
|
Operating Expenses
|
-223.2m
USD
|
Operating Income
|
456.3m
USD
|
Other Expenses
|
-39.9m
USD
|
Net Income
|
416.4m
USD
|
MEDP Profitability Score
Profitability Due Diligence
Medpace Holdings Inc's profitability score is 76/100. The higher the profitability score, the more profitable the company is.

Score
Medpace Holdings Inc's profitability score is 76/100. The higher the profitability score, the more profitable the company is.
MEDP Solvency Score
Solvency Due Diligence
Medpace Holdings Inc's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Score
Medpace Holdings Inc's solvency score is 77/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MEDP Price Targets Summary
Medpace Holdings Inc
According to Wall Street analysts, the average 1-year price target for
MEDP
is 306.75 USD
with a low forecast of 272.7 USD and a high forecast of 359.1 USD.
Dividends
Current shareholder yield for MEDP is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MEDP
stock under the Base Case scenario is
286.85
USD.
Compared to the current market price of 298.25 USD,
Medpace Holdings Inc
is
Overvalued by 4%.